73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A novel method to better predict the outgrowth of ductal carcinoma in situ

A novel method to better predict the outgrowth of ductal carcinoma in situ

by Netherlands Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.002An international team of researchers led by the Netherlands Cancer Institu

A novel method to better predict the outgrowth of ductal carcinoma in situ

by Netherlands Cancer InstituteGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.002An international team of researchers led by the Netherlands Cancer Institu
Researchers report results in rare gynecologic cancers from DART immunotherapy trial

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat

Researchers report results in rare gynecologic cancers from DART immunotherapy trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of pat
Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

by Strata OncologyDevelopment of an integrative immunotherapy response score (IRS) model to stratify PD-(L)1 therapy benefit in patients with advanced solid tumors.aReal-world treatment an

Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

by Strata OncologyDevelopment of an integrative immunotherapy response score (IRS) model to stratify PD-(L)1 therapy benefit in patients with advanced solid tumors.aReal-world treatment an
Team discovers broken 'brake' of cancer mutation machine

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that
Researchers revisit potent drug as promising treatment for acute leukemia

Researchers revisit potent drug as promising treatment for acute leukemia

by National University of SingaporeChemical screening using the GIMAP enhancer reporter system. (A) Overview of the chemical screening strategy. Using a liquid handling workstation, 2,961 compoun

Researchers revisit potent drug as promising treatment for acute leukemia

by National University of SingaporeChemical screening using the GIMAP enhancer reporter system. (A) Overview of the chemical screening strategy. Using a liquid handling workstation, 2,961 compoun
Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic

Treatment with immunotherapy alone produces 'exceptional' response rates in some melanoma patients

by Ohio State University Medical CenterMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Data from a national clinic
Study finds senescent immune cells promote lung tumor growth

Study finds senescent immune cells promote lung tumor growth

by Mayo ClinicGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.006Macrophages are a type of white blood cell that are among the body's first line of defe

Study finds senescent immune cells promote lung tumor growth

by Mayo ClinicGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.006Macrophages are a type of white blood cell that are among the body's first line of defe
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l
Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord

Chemotherapy-resistant ovarian cancer cells protect their neighbors, shows study

by University of PittsburghCredit: Unsplash/CC0 Public DomainCertain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, accord
Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin

Researchers overcome treatment resistance mechanism in one of the most aggressive types of breast cancer

by IMIM (Hospital del Mar Medical Research Institute)Stromal traits define resistance to trastuzumab.aPercentage of CD45+ cells in HER2+ BC tumors comparing relapse-free (blue) to relapsin
Investigators find disparities in mesothelioma survival due to social determinants, limited access

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af